Sort
30,917 grants matching “tumor microenvironment”
Surgical Oncologists as Scientists (SOAS) Training Program
$336,735Jason Keith Sicklick · University Of California, San Diego · T32 · FY2025 · CA
Understanding How Breast Cancers Activate and Respond to the Systemic Environment
$336,717Sandra S McAllister · Brigham And Women'S Hospital · R01 · FY2015 · CA
Photodynamic Therapy Affects on the Tumor Microenvironment
$336,685Charles Joseph Gomer · Children'S Hospital Of Los Angeles · R01 · FY2008 · CA
Role for TbetaRIII Shedding in the Tumor Microenvironment
$336,648Gerard C Blobe · Duke University · R01 · FY2022 · CA
Genetically Engineered Mouse Models Shared Resource
$336,636Shondra Michelle Miller · St. Jude Children'S Research Hospital · P30 · FY2025 · CA
Engineering tissue inhibitor of metalloproteinases-2 (TIMP-2) for triple negative breast cancer therapy
$336,617Evette S Radisky · Mayo Clinic Jacksonville · R01 · FY2021 · CA
Three-dimensional Model of Human Ewing Sarcoma
$336,611Antonios G. Mikos · Rice University · R01 · FY2014 · CA
OV therapy induced changes in tumor secretome and their impact on therapy
$336,602Balveen Kaur · Ohio State University · R01 · FY2014 · NS
Cytokine regulation of RA synoviocyte phenotype
$336,600Hospital For Special Surgery · R01 · FY2005 · AR
Cytokine regulation of RA synoviocyte phenotype
$336,600Hospital For Special Surgery · R01 · FY2004 · AR
Microenvironmental Influences in Cancer
$336,559Jin Chen · Vanderbilt University · T32 · FY2011 · CA
EPS8 as a Driver of the Oral Cancer Initiating Cell Phenotype.
$336,442William Andrew Yeudall · Virginia Commonwealth University · R01 · FY2014 · DE
IDO1 and Immunotolerance in Glioblastoma
$336,419Derek Alan Wainwright · Northwestern University At Chicago · R01 · FY2017 · NS
Pre-Clinical Evaluation Core
$336,388Mandi J. Lopez · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2023 · GM
Identifying/Targeting Mechanisms of Lymphomagenesis Driven by CREBBP Inactivation
$336,377Michael Richard Green · University Of Nebraska Medical Center · R01 · FY2016 · CA
Mechanisms of Immune-mediated Tumor Cell Destruction
$336,369Thomas Sayers · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Polymeric Nanomedicines of Small Molecules and miRNA for Treating Pancreatic Canc
$336,360Ram I Mahato · University Of Nebraska Medical Center · R01 · FY2015 · EB
Converting Cold to Hot Tumor Microenvironment in Prostate Cancer by Targeting Chromatin Effector
$336,327Xin Lu · University Of Notre Dame · R01 · FY2024 · CA
Molecular basis for HIV therapy-linked osteopenia
$336,307Jeffrey C Laurence · Weill Medical Coll Of Cornell Univ · R01 · FY2006 · DK
Biospecimen Repository and Pathology Core
$336,302George Plitas · Sloan-Kettering Inst Can Research · P50 · FY2020 · CA
Colorectal carcinogenesis and Fusobacterium nucleatum: oncomicrobe, oncometabolites, and oncoimmunology
$336,288Wendy S. Garrett · Harvard School Of Public Health · R01 · FY2019 · CA
Dietary intervention of non-classical Wnt signaling
$336,263Rajeev S Samant · University Of Alabama At Birmingham · R01 · FY2020 · CA
Targeted therapy for breast cancer with osteolytic bone damage
$336,263Selvarangan Ponnazhagan · University Of Alabama At Birmingham · R01 · FY2018 · CA
Dietary intervention of non-classical Wnt signaling
$336,263Rajeev S Samant · University Of Alabama At Birmingham · R01 · FY2017 · CA
Targeted therapy for breast cancer with osteolytic bone damage
$336,263Selvarangan Ponnazhagan · University Of Alabama At Birmingham · R01 · FY2017 · CA